Publications

Lea I, Moore HD, Latchman DS. 1991. Differential expression of the mouse U1a and U1b SnRNA genes is not dependent on sequence differences in the octamer motif. Biochem J 277( Pt 3):719–722; doi: 10.1042/bj2770719.

Dalessandri KM, Giri SN, Robison TW, Hayashi HH, Talken L. 1991. No change in alpha₁ adrenoreceptors in canine femoral arteries after lumbar sympathectomy. J Invest Surg 4(2):137-140; doi: 10.3109/08941939109140773.

Couture-Haws L, Abbott BD, Birnbaum LS. 1990. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Recent advances in understanding the mechanism. Teratol 42(6):619-627; doi: 10.1002/tera.1420420606.

Couture LA, Harris MW, Birnbaum LS. 1990. Characterization of the peak period of sensitivity for the induction of hydronephrosis in C57BL/6N mice following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 15(1):142-150; doi: 10.1016/0272-0590(90)90171-f.

Robison TW, Sevanian A, Forman HJ. 1990. Inhibition of arachidonic acid release by nordihydroguaiaretic acid and its antioxidant action in rat alveolar macrophages and Chinese hamster lung fibroblasts. Toxicol Appl Pharmacol 105(1):113-122; doi: 10.1016/0041-008x(90)90363-y.

Robison TW, Forman HJ. 1990. t-Butyl hydroperoxide stimulates alveolar macrophage biosynthesis of cyclooxygenase products. Prostaglandins 40(1):13-28; doi: 10.1016/0090-6980(90)90053-x.

Robison TW, Duncan DP, Forman HJ. 1990. Chemoattractant and leukotriene B4 production from rat alveolar macrophages exposed to nitrogen dioxide. Amer J Resp Cell Molecular Biol 3(1):21-26; doi: 10.1165/ajrcmb/3.1.21.

Robison TW, Duncan DP, Coates TD, Forman HJ. 1990. Inhibition of production of LTB4 and chemotactic agent from rat alveolar macrophages treated with t- butyl hydroperoxide is independent of ATP depletion. Biochim Biophys Acta 1045(1):9-16; doi: 10.1016/0005-2760(90)90197-6.

Birnbaum LS, Couture LA, Elwell MR. 1989. Subchronic effects of exposure to octachlorodibenzo-p-dioxin (OCDD). Chemosphere. 18(1-6):389-390; doi: 10.1016/0045-6535(89)90145-8.

Couture LA, Harris MW, Birnbaum LS. 1989. Developmental toxicity of 2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF) in the Fischer 344 rat. Fund Appl Toxicol 12:358-366; doi: 10.1016/0272-0590(89)90052-3.

Robison TW, Giri SN, Wilson DW. 1989. Effects of chronic administration of doxorubicin on myocardial creatine phosphokinase and antioxidant defenses and levels of lipid peroxidation in tissues and plasma of rats. J Biochem Toxicol 4(2):87-94; doi: 10.1002/jbt.2570040204.

Birnbaum LS, Couture LA. 1988. Disposition of octachlorodibenzo-p-dioxin (OCDD) in male rats. Toxicol Appl Pharmacol. 93(1):22-30; doi: 10.1016/0041-008X(88)90022-1.

Couture LA, Elwell MR, Birnbaum LS. 1988. Dioxin-like effects observed in male rats following exposure to octachlorodibenzo-p-dioxin (OCDD) during a 13-week study. Toxicol Appl Pharmacol. 93(1):31-46; doi: 10.1016/0041-008X(88)90023-3.

Robison TW, Duncan DP, Forman HJ. 1988. Kinetics of uptake and distribution of arachidonic acid by rat alveolar macrophages. Prostaglandins 36(4):443-461; doi: 10.1016/0090-6980(88)90042-1.

Rish W. 1988. Review of studies related to uncertainty in risk analysis. ORNL/TM 10776 (with R.J. Marnicio). Report to U.S. Environmental Protection Agency, Office of Radiation Programs, Analysis and Support Division, Oak Ridge National Laboratory.

Robison TW, Giri SN. 1987. Effects of chronic administration of doxorubicin on myocardial alpha-adrenergic receptors, histamine, cyclic nucleotides, calcium, norepinephrine, calmodulin, and guanylate cyclase activity, and plasma catecholamines in rats. Virchows Archiv B 54(3):182-189; doi: 10.1007/BF02899210.

Robison TW, Giri SN. 1987. Effects of chronic administration of doxorubicin on plasma levels of prostaglandins, TxB₂ and fatty acid in rats. Cancer Chemother Pharmacol 19(3):213-220; doi: 10.1007/BF00252975.

Giri SN, Sanford DA, Robison TW, Tyler NK. 1987. Impairment in coupled beta-adrenergic receptor and adenylate cyclase system during bleomycin-induced lung fibrosis in hamsters. Exp Lung Res 13(4):401-416; doi: 10.3109/01902148709069601.

Robison TW, Giri SN. 1987. Effects of chronic administration of doxorubicin on heart phospholipase A₂ activity and in vitro synthesis and degradation of prostaglandins in rats. Prostaglandins Leukot Med 26(1):59-74; doi: 10.1016/0262-1746(87)90152-1.

Robison TW, Giri SN. 1986. Effects of chronic administration of doxorubicin on myocardial beta-adrenergic receptors. Life Sci 39(8):731-736; doi: 10.1016/0024-3205(86)90021-4.